Wave Life Sciences

WVE
3.4803.42% ( +0.115 )
Closed: Nov 9, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -3.26, within the reasonable range, cheaper than 34.36% of the time in the past 5 years, and the industry ranks 144/256, the industry Median -1.08.

-3.26xP/E
Stock price$3.48Earnings per share$-1.07

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
03876114152

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAYZFUSBayer Aktiengesellschaft
-37.57x--$62.45B
BAYRYUSBayer
-37.61x--$62.52B
VTRSUSViatris
-38.65x97.55%$23.49B
ELANUSElanco Animal Health
-91.26x141.06%$13.42B
ABVXUSAbivax SA
-16.31x22.99%$7.58B
AXSMUSAxsome Therap
-44.80x29.69%$7.05B
CURLFUSCuraleaf Holdings, Inc.
-333.04x--$6.87B
VREOFUSVIREO GROWTH INC
-95.96x--$6.44B
BLTEUSBelite Bio
-62.04x29.87%$6.35B
MANEUSVeraDermics
-57.67x97.44%$6.01B
DFTXUSDefinium Therapeutics
-13.44x54.55%$4.76B
AMLXUSAmylyx Pharmaceuticals
-23.80x1.63%$3.88B
ELVNUSEnliven Therapeutics
-33.43x2.84%$3.79B
TARSUSTarsus Pharmaceuticals
-4.97x879.07%$3.49B
BHCUSBausch Health
-3.74x511.90%$3.14B
XERSUSXeris Biopharma
-446.06x--$2.90B
RGCUSRegencell Bioscience
-238.17x--$2.79B
MBXUSMBX Biosciences
-24.96x31.12%$2.60B
PHVSUSPharvaris BV
-12.21x10.43%$2.42B
SEPNUSSepterna
-97.72x22.79%$2.37B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.